Surfactant Replacement Therapy (SRT) is a medical treatment administered to newborns, primarily preterm infants, to address respiratory distress syndrome (RDS). RDS occurs due to a deficiency of pulmonary surfactant, a substance that reduces surface tension within the lungs, preventing alveolar collapse and facilitating efficient gas exchange.
